MAZE - Maze Therapeutics, Inc.

QQQ $ 602.61 $ 4.22 (0.71 %)

DIA $ 463.04 $ 0.00 (0 %)

SPY $ 665.11 $ 2.94 (0.44 %)

TLT $ 90.76 $ -0.20 (-0.22 %)

GLD $ 387.41 $ 6.60 (1.73 %)

Previous Close

$ 29.26

Open

$ 28.31

Bid

$ 27.75 x 2

Ask

$ 29.99 x 7

Day's Range

$ 28.31 - $ 29.44

52 Week Range

$ 6.71 - $ 29.66

Volume

433,624

Average Volume

Market Cap

1.28B

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Maze Therapeutics Expands Board Leadership...
10/06/2025 11:13:34

JP Morgan Maintains Overweight on Maze The...
09/29/2025 12:52:24

JP Morgan analyst Anupam Rama maintains Maze Therapeutics (NASDAQ: MAZE) with a Overweight and raises the price target from ...

HC Wainwright & Co. Reiterates Buy on Maze...
09/18/2025 10:41:15

HC Wainwright & Co. analyst Ananda Ghosh reiterates Maze Therapeutics (NASDAQ:MAZE) with a Buy and maintains $50 price t...

Guggenheim Maintains Buy on Maze Therapeut...
09/15/2025 12:40:45

Guggenheim analyst Debjit Chattopadhyay maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy and raises the price target fro...

HC Wainwright & Co. Maintains Buy on Maze ...
09/12/2025 12:07:17

HC Wainwright & Co. analyst Ananda Ghosh maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy and raises the price targe...

BTIG Maintains Buy on Maze Therapeutics, R...
09/12/2025 11:02:41

BTIG analyst Julian Harrison maintains Maze Therapeutics (NASDAQ:MAZE) with a Buy and raises the price target from $30 to $37.

maze-shares-jump-as-investors-bet-big-on-experimental-treatments-potential

Maze Shares Jump As Investors Bet Big On E...
09/11/2025 18:05:57

Maze's MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and...

12 Health Care Stocks Moving In Thursday's...
09/11/2025 17:06:18

maze-therapeutics-opendoor-technologies-oxford-industries-vnet-group-and-other-big-stocks-moving-higher-on-thursday

Maze Therapeutics, Opendoor Technologies, ...
09/11/2025 15:09:08

12 Health Care Stocks Moving In Thursday's...
09/11/2025 12:10:10

Maze Therapeutics Secures $150M In Oversub...
09/11/2025 11:37:42

Maze Therapeutics, Inc. (NASDAQ:MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines...

Maze Therapeutics Reports Clinical Results...
09/11/2025 11:33:10

Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for bo...

BTIG Initiates Coverage On Maze Therapeuti...
09/02/2025 12:12:27

BTIG analyst Julian Harrison initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Buy rating and announces Price Tar...

Maze Therapeutics Appoints Misbah Tahir CF...
09/02/2025 11:05:55

Maze Therapeutics Q2 EPS $(0.77) Misses $(...
08/12/2025 20:22:00

12 Health Care Stocks Moving In Monday's A...
07/28/2025 21:05:57

this-celsius-holdings-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday

This Celsius Holdings Analyst Begins Cover...
07/23/2025 13:58:26

HC Wainwright & Co. Initiates Coverage On ...
07/23/2025 10:26:59

HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Buy rating and ann...

12 Health Care Stocks Moving In Wednesday'...
07/16/2025 21:06:00

Wedbush Initiates Coverage On Maze Therape...
07/08/2025 12:56:58

Wedbush analyst Laura Chico initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Outperform rating and announces Pri...